Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
about
Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuckRecognition of human oncogenic viruses by host pattern-recognition receptorsCurrent and future antiviral drug therapies of hepatitis B chronic infectionInterplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysPoly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.Antiviral therapies and prospects for a cure of chronic hepatitis B.Oral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model.Innate immune recognition of hepatitis B virus.Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication.Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.Chronic hepatitis B virus in young adults: the need for new approaches to management.Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro studyAssociation of Mutations in Toll-like Receptor 2 Signaling Genes With Fulminant Form of Hepatitis B-Related Acute Liver Failure.Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.Novel targets for hepatitis B virus therapy.The IL-1R/TLR signaling pathway is essential for efficient CD8(+) T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model.Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment.TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population.Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.Interplay between hepatitis B virus and innate immune signaling pathways
P2860
Q26828598-154E6924-3180-48DE-A1D0-4743D55FB0C2Q27010116-C80F9955-FA39-4998-9333-FA6C00B95599Q28084820-BC703EF1-79E5-41D9-9D4E-622A5E903ACDQ30854409-DA518FE8-DEDA-446B-A18F-5E9DC1679BBFQ34137297-E32F806F-22B3-43FA-BCF5-9967FF78E734Q34262302-CEE8680E-4EB9-4971-BE3C-CF379DBB08C5Q35008279-F774D4EC-AF6D-4C29-953B-F35C6586DEDCQ35245231-1FFC992E-22F1-4AAE-A67B-C12FDF55617FQ35598073-3180084C-D834-47D7-9DB2-35F7FAC80D0AQ36080441-28CB16A0-8B6E-405E-BDF2-752B595DC9FDQ36249804-508387D3-B4E7-4050-B6B6-7EA49E268021Q36860286-52B80277-55A9-43A1-816B-5A11E190BB17Q37550327-D5DF722B-733C-4313-904D-954FECAB691DQ38180983-B6BDE3B6-799B-4F56-83E6-5EF9ABBD0A48Q38232829-B1664165-0597-4561-8E30-724B7BB1FB39Q38270733-D6F282CA-D462-4541-99A6-E1DEEBAFB844Q38618869-75BFB9C1-C8A6-413C-BF98-1DDD81AD09D0Q38774271-24624A8E-6769-4FE5-AE9A-0F9B72AE12E0Q38886366-94C941CB-2D6E-427D-8533-8C61D33D2612Q38905804-37B69C61-950C-4312-819B-B98A3059A222Q39067316-387343C9-20C5-475C-B7CB-EB96EDCFF2ADQ40102035-3304B0AC-139D-47B9-9E75-0587DD0400A3Q40325365-7A02AFF9-BEC5-42C6-8FB9-960E2864BEE8Q42223356-F82E72EE-58A1-446E-A3AF-0CADDC343BE9Q45323617-51F3ED86-5363-4F50-8471-132BB058EF86Q47553095-000F647E-4147-4A19-94D7-3E69D0CE4145Q47555967-40ED1DA8-EF91-4880-9227-A21F6E88B1E3Q52620810-E7DA7AFF-FD5F-4D7B-BCB4-E18D0D416EE8Q57207207-9F4FF740-2B8C-4A67-90A5-EDC8BADEF841
P2860
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
@en
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
@nl
type
label
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
@en
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
@nl
prefLabel
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
@en
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
@nl
P2093
P50
P1476
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection
@en
P2093
Dongliang Yang
Hongyan Liu
Michael Roggendorf
Xiaoyong Zhang
Zhiyong Ma
P304
P356
10.1016/J.JHEP.2012.05.004
P577
2012-05-19T00:00:00Z